Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1886 | 2370 | 43.2 | 86% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 880 | 10788 | HEREDITARY HEMORRHAGIC TELANGIECTASIA//ENDOGLIN//TGF BETA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TGF BETA RECEPTORS | Author keyword | 17 | 35% | 2% | 39 |
| 2 | TGF BETA RECEPTOR | Author keyword | 12 | 30% | 1% | 32 |
| 3 | MED MED CELL BIOL | Address | 9 | 55% | 1% | 12 |
| 4 | BIOL CELLULES SOUCHES SOMAT HUMAINES | Address | 6 | 100% | 0% | 4 |
| 5 | CHEMOPREVENT | Address | 4 | 14% | 1% | 24 |
| 6 | TRANSFORMING GROWTH FACTOR BETA RECEPTORS | Author keyword | 3 | 29% | 0% | 10 |
| 7 | CELL BIOL NC1 | Address | 3 | 100% | 0% | 3 |
| 8 | CELL SUR E RECOGNIT GRP | Address | 3 | 100% | 0% | 3 |
| 9 | TGF BETA ISOFORMS | Author keyword | 2 | 33% | 0% | 6 |
| 10 | AUTOCRINE HYPOTHESIS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FACTOR BETA 1 | 110 | 27% | 15% | 355 |
| 2 | MOLECULAR WEIGHT COMPLEX | 18 | 26% | 2% | 58 |
| 3 | AKR 2B CELLS | 17 | 63% | 1% | 17 |
| 4 | DEOXYRIBONUCLEIC ACID CLONING | 15 | 46% | 1% | 24 |
| 5 | MEMBRANE PROTEOGLYCAN | 14 | 39% | 1% | 28 |
| 6 | INHIBITORY RESPONSES | 14 | 51% | 1% | 19 |
| 7 | BETAGLYCAN | 13 | 31% | 1% | 35 |
| 8 | CONCOMITANT LOSS | 13 | 80% | 0% | 8 |
| 9 | ACCOMPANIES VIRAL TRANSFORMATION | 12 | 75% | 0% | 9 |
| 10 | HETEROOLIGOMERIC COMPLEXES | 12 | 47% | 1% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Regulation of immune responses by TGF-beta | 1998 | 1214 | 116 | 42% |
| THE TRANSFORMING GROWTH-FACTOR-BETA FAMILY | 1990 | 2875 | 240 | 55% |
| TRANSFORMING GROWTH-FACTOR-BETA IN TISSUE FIBROSIS | 1994 | 2207 | 65 | 28% |
| Transforming growth factor-beta: A general review | 1996 | 327 | 104 | 48% |
| Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis | 2000 | 198 | 249 | 37% |
| TRANSFORMING GROWTH-FACTOR-BETA - RECENT PROGRESS AND NEW CHALLENGES | 1992 | 714 | 37 | 62% |
| PHYSIOLOGICAL ACTIONS AND CLINICAL-APPLICATIONS OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) | 1993 | 640 | 76 | 55% |
| TGF-BETA STIMULATION AND INHIBITION OF CELL-PROLIFERATION - NEW MECHANISTIC INSIGHTS | 1990 | 947 | 18 | 67% |
| TGF-beta receptor signaling | 1997 | 234 | 267 | 41% |
| The role for transforming growth factor-beta (TGF-beta) in human cancer | 1999 | 241 | 498 | 28% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED MED CELL BIOL | 9 | 55% | 0.5% | 12 |
| 2 | BIOL CELLULES SOUCHES SOMAT HUMAINES | 6 | 100% | 0.2% | 4 |
| 3 | CHEMOPREVENT | 4 | 14% | 1.0% | 24 |
| 4 | CELL BIOL NC1 | 3 | 100% | 0.1% | 3 |
| 5 | CELL SUR E RECOGNIT GRP | 3 | 100% | 0.1% | 3 |
| 6 | MED MED PLAST SURG | 2 | 67% | 0.1% | 2 |
| 7 | MED ONCOL MED MED | 2 | 67% | 0.1% | 2 |
| 8 | MEDVANDERBILT CANC | 2 | 67% | 0.1% | 2 |
| 9 | BIOTECHNOL CELL SUR E RECOGNIT GRP | 1 | 100% | 0.1% | 2 |
| 10 | CANC ETIOLEXPTL CARCINOGENESIS BLDG 37 | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000199721 | ALK5 INHIBITOR//CELL BASED LUCIFERASE REPORTER ASSAY//TGFB1 |
| 2 | 0.0000168629 | PHENOTYPE INDUCTION//PHOSPHORYLATED SMAD2//SMAD UBIQUITINATION REGULATORY FACTOR 2 |
| 3 | 0.0000158122 | LTBP//ALPHA V BETA 6//INTEGRIN ALPHAVBETA6 |
| 4 | 0.0000140921 | SMAD//SMAD4//SNON |
| 5 | 0.0000138889 | TRANSFORMING GROWTH FACTOR ALPHA//TGF ALPHA//HTGF ALPHA |
| 6 | 0.0000128617 | CTHRC1//COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1//CAROTID ARTERY RESTENOSIS |
| 7 | 0.0000120112 | BASIC CANC//SIALOGLYCOPEPTIDE//DENSITY INHIBITION |
| 8 | 0.0000119008 | HUMAN TOXICOL PROGRAM//PROGRAM FREE RAD RADIAT BIOL//BIOQUIM BIOQUIM BIOL MOL |
| 9 | 0.0000095266 | GROWTH HORMONE BIOL//IN SITU SETTING CEMENT//POLYD L LACTIDE COATING |
| 10 | 0.0000072450 | ANTITUMOR IMMUN//NN BLOKCHIN CANC//HOCL SIGNALING PATHWAY |